These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 698929)

  • 41. Inhibition of disease flare with diethylstilbestrol diphosphate and chlormadinone acetate administration for two weeks prior to slow-releasing leuprolide acetate in prostatic cancer patients.
    Ohuchi H; Noguchi K; Kinoshita Y; Hosaka M; Kawasaki C; Miura T; Kondo I; Harada M
    Hinyokika Kiyo; 2000 Aug; 46(8):531-6. PubMed ID: 11019371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Humoral and cellular immunity in prostatic adenocarcinoma].
    Pérez Herrero F; Alfonso Sánchez M; Gutierrez Mínguez E; Urrutia Avisrror M; Montero Gómez J
    Actas Urol Esp; 1983; 7(6):433-6. PubMed ID: 6670612
    [No Abstract]   [Full Text] [Related]  

  • 44. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
    Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
    Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Massive pleural effusions from prostatic lymphangitic carcinomatosis: resolution with endocrine therapy.
    Heffner JE; Duffey DJ; Schwarz MI
    Arch Intern Med; 1982 Feb; 142(2):375-6. PubMed ID: 7059263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Some immunologic characteristics of carcinoma of the colon and rectum.
    Elias EG; Elias LL
    Surg Gynecol Obstet; 1975 Nov; 141(5):715-8. PubMed ID: 1198304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M; Drury RE; Kadohama N
    Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
    Neubauer BL; Best KL; Goode RL; Heiman ML; Hoover DM; Robertson DW; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
    Cancer Res; 1992 Sep; 52(17):4663-71. PubMed ID: 1511432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological basis of close-contact sensitization to osteosarcoma.
    Powell A; Sloss AM; Makley JT
    Cancer Res; 1979 Feb; 39(2 Pt 2):658-9. PubMed ID: 310710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of sensitized leukocyte's in vitro reactivity by circulating immune complexes in prostate cancer.
    Bhatti R; Shaw M; Ray P
    Experientia; 1987 Aug; 43(8):916-7. PubMed ID: 3622734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction].
    Grishchenko AM; Grinevich IuA; Alferov AN; Redkousova SF; Sen'ko LN
    Vrach Delo; 1978 Aug; (8):28-32. PubMed ID: 695500
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunodiagnosis of prostate cancer: an evaluation of cell-mediated immunity.
    Bhatti RA; Guinan PD; Nagubadi SR; Khin W
    Prostate; 1982; 3(4):415-9. PubMed ID: 7122334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Severe acute thrombosis induced by high dosage of estrogen therapy].
    Danis RK; Lasry G; Melliere D; Beaumont V; Botto H
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2396. PubMed ID: 673816
    [No Abstract]   [Full Text] [Related]  

  • 54. Leukocyte adherence inhibition microtest for the detection of cell-mediated immunity to tumor in gastric cancer patients.
    Koyama S; Sakita T; Fukutomi H; Kawakita I; Tamura N
    Oncology; 1981; 38(1):13-7. PubMed ID: 7003459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombocytopenia during diethylstilbestrol diphosphate (stilphostrol) infusion for carcinoma of the prostate.
    Nachtsheim DA; McPherson RA; Pollen JJ; Schmidt JD
    Prostate; 1980; 1(1):105-9. PubMed ID: 7279796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiandrogenic suppression of lymphocytic blastogenesis: in vitro and in vivo observations.
    Ablin RJ; Burns GR; Guinan P; Bush IM
    Experientia; 1974 Nov; 30(11):1351-3. PubMed ID: 4435189
    [No Abstract]   [Full Text] [Related]  

  • 57. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma.
    Cornfield DB; Rossman RE
    South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376
    [No Abstract]   [Full Text] [Related]  

  • 58. Responsiveness of lymphocytes to soluble extracts of prostatic tumors and abrogation by serum-blocking factor(s).
    Bhatti RA; Guinan PD; McKiel CF; Bush IM; Bruns GR; Flanagan MJ; Ablin RJ
    Urology; 1977 Mar; 9(3):314-6. PubMed ID: 841812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary report.
    Ablin RJ; Bhatti RA; Guinan PD; Bush IM
    Experientia; 1979 Nov; 35(11):1510-11. PubMed ID: 510506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Indicators of cellular immunity in patients with ovarian cancer and methods of their correction].
    Stambrovskaia AA; Siparov IN
    Akush Ginekol (Mosk); 1987 Jul; (7):43-6. PubMed ID: 3688330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.